TMA-Bridge

The TMA-Bridge project is aimed at promoting the creation of a European eHealth Area, favouring the mobility of citizens and patients in the European Union.To this end, a set of concrete recommendations has been addressed to the EC and to the governments of the EU Member States.

The Telemedicine Alliance (TMA), in its first phase of work, formulated a Vision for citizen-centred eHealth services by 20107. A key outcome of this study shown that the issue of interoperability was a major obstacle to the implementation of eHealth.

The overall goal of TMA-Bridge, the second phase of work of the TMA,was to provide a Strategic Plan for transnational eHealth interoperability with creative, citizencentred, action-oriented, strategic actionable recommendations. The focus of the plan is to enable the stakeholders to take action to achieve actual and sustainable interoperability. These stakeholders came from all areas, including political, organizational, social, and technical.

The Strategic plan and its recommendations to the European Commission and the EU Member States are in fact relevant for all stakeholders. Indeed, all stakeholders must take heed to these recommendations, and take coordinated and concerted action in order that the immense investment in eHealth now being expended in the individual Member States to contribute to improved healthcare in those States, will also facilitate interoperable trans-national services across Europe. This will help the mobile patient and health professional and could have farreaching implications for ICT development in Europe: the full investment and creative forces of industry can be unleashed in this lucrative market, thus improving the economic health of European industry, as well as that of its citizens only with established and interoperable standards across Europe.

For further information, please visit:
http://www.esa.int/telemedicine-alliance

Project co-ordinator:
European Space Agency (ESA)

Partners:

  • ESA, European Space Research & Technology Centre (ESTEC), Noordwijk, (NL)
  • WHO - Regional Office for Europe, Office for Integrated Health Care Services, Barcelona, (ES)
  • ITU Telecommunication Development Bureau, Geneva, (CH)

Timetable: from 08/04 – to 07/05

Total cost: € 550.000,00

EC funding: € 550.000,00

Instrument: SSA

Project Identifier: IST-2004-507871

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...